Real-world Effectiveness of First-Line Azacitidine or Decitabine with or Without Venetoclax in Acute Myeloid Leukemia Patients Unfit for Intensive Therapy
EUROPEAN JOURNAL OF HAEMATOLOGY(2024)
Key words
AML,azacitidine,decitabine,hypomethylating agent,real-world data,venetoclax
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined